nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Fluorouracil—skin cancer	0.0769	0.114	CbGbCtD
Nifedipine—CYP1A2—Imiquimod—skin cancer	0.0529	0.0781	CbGbCtD
Nifedipine—CYP1A1—Dacarbazine—skin cancer	0.0497	0.0734	CbGbCtD
Nifedipine—CYP2C8—Vismodegib—skin cancer	0.0474	0.0699	CbGbCtD
Nifedipine—CYP2E1—Dacarbazine—skin cancer	0.0384	0.0567	CbGbCtD
Nifedipine—CYP2A6—Fluorouracil—skin cancer	0.0341	0.0504	CbGbCtD
Nifedipine—CYP2C9—Vismodegib—skin cancer	0.033	0.0488	CbGbCtD
Nifedipine—ABCB1—Vismodegib—skin cancer	0.0321	0.0473	CbGbCtD
Nifedipine—CYP1A2—Vemurafenib—skin cancer	0.029	0.0428	CbGbCtD
Nifedipine—CYP3A4—Imiquimod—skin cancer	0.0277	0.0409	CbGbCtD
Nifedipine—CYP3A4—Temozolomide—skin cancer	0.0277	0.0409	CbGbCtD
Nifedipine—ABCC2—Docetaxel—skin cancer	0.0267	0.0394	CbGbCtD
Nifedipine—CYP2D6—Vemurafenib—skin cancer	0.0239	0.0353	CbGbCtD
Nifedipine—CYP1A2—Dacarbazine—skin cancer	0.0222	0.0328	CbGbCtD
Nifedipine—CYP3A4—Vismodegib—skin cancer	0.0192	0.0284	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—skin cancer	0.0178	0.0263	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0178	0.0263	CbGbCtD
Nifedipine—CACNA1S—pes—skin cancer	0.0177	0.239	CbGeAlD
Nifedipine—ABCB1—Dactinomycin—skin cancer	0.0168	0.0249	CbGbCtD
Nifedipine—CYP2C8—Fluorouracil—skin cancer	0.0168	0.0248	CbGbCtD
Nifedipine—CYP3A4—Vemurafenib—skin cancer	0.0152	0.0224	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—skin cancer	0.0134	0.0197	CbGbCtD
Nifedipine—CYP1A2—Fluorouracil—skin cancer	0.013	0.0192	CbGbCtD
Nifedipine—CYP2C9—Fluorouracil—skin cancer	0.0117	0.0173	CbGbCtD
Nifedipine—ABCB1—Docetaxel—skin cancer	0.0087	0.0128	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—skin cancer	0.00521	0.00769	CbGbCtD
Nifedipine—CACNA1D—ear—skin cancer	0.00408	0.0552	CbGeAlD
Nifedipine—KCNA1—nerve—skin cancer	0.00385	0.0521	CbGeAlD
Nifedipine—CALM2—ear—skin cancer	0.00248	0.0335	CbGeAlD
Nifedipine—CALM1—ear—skin cancer	0.00247	0.0334	CbGeAlD
Nifedipine—CALM2—nerve—skin cancer	0.00156	0.0211	CbGeAlD
Nifedipine—CALM1—nerve—skin cancer	0.00155	0.021	CbGeAlD
Nifedipine—CYP1A1—skin epidermis—skin cancer	0.0014	0.0189	CbGeAlD
Nifedipine—CALM2—endothelium—skin cancer	0.00133	0.018	CbGeAlD
Nifedipine—CALM1—endothelium—skin cancer	0.00132	0.0179	CbGeAlD
Nifedipine—CALM2—hair follicle—skin cancer	0.00131	0.0177	CbGeAlD
Nifedipine—CALM2—blood vessel—skin cancer	0.00123	0.0166	CbGeAlD
Nifedipine—CALM1—blood vessel—skin cancer	0.00122	0.0165	CbGeAlD
Nifedipine—CALM3—nipple—skin cancer	0.00113	0.0153	CbGeAlD
Nifedipine—CACNA1C—connective tissue—skin cancer	0.000956	0.0129	CbGeAlD
Nifedipine—KCNA1—head—skin cancer	0.000914	0.0124	CbGeAlD
Nifedipine—CALM2—nipple—skin cancer	0.000886	0.012	CbGeAlD
Nifedipine—CACNA1H—female reproductive system—skin cancer	0.000885	0.012	CbGeAlD
Nifedipine—CALM1—nipple—skin cancer	0.000882	0.0119	CbGeAlD
Nifedipine—CALM2—neck—skin cancer	0.000877	0.0119	CbGeAlD
Nifedipine—CALM1—neck—skin cancer	0.000873	0.0118	CbGeAlD
Nifedipine—CACNB2—head—skin cancer	0.000698	0.00943	CbGeAlD
Nifedipine—CYP1A2—nipple—skin cancer	0.000687	0.00929	CbGeAlD
Nifedipine—CYP1A1—nipple—skin cancer	0.000678	0.00917	CbGeAlD
Nifedipine—CACNA1C—female reproductive system—skin cancer	0.000674	0.00911	CbGeAlD
Nifedipine—CALM3—mammalian vulva—skin cancer	0.000659	0.00891	CbGeAlD
Nifedipine—CACNA2D1—head—skin cancer	0.000655	0.00886	CbGeAlD
Nifedipine—CALM2—connective tissue—skin cancer	0.000629	0.0085	CbGeAlD
Nifedipine—CALM1—connective tissue—skin cancer	0.000626	0.00846	CbGeAlD
Nifedipine—ABCC3—female reproductive system—skin cancer	0.000613	0.00829	CbGeAlD
Nifedipine—CACNA1D—head—skin cancer	0.00061	0.00825	CbGeAlD
Nifedipine—CALM2—epithelium—skin cancer	0.000597	0.00807	CbGeAlD
Nifedipine—CALM1—epithelium—skin cancer	0.000594	0.00803	CbGeAlD
Nifedipine—CALM2—skin of body—skin cancer	0.000568	0.00767	CbGeAlD
Nifedipine—CALM1—skin of body—skin cancer	0.000565	0.00764	CbGeAlD
Nifedipine—CACNA1C—head—skin cancer	0.000563	0.00761	CbGeAlD
Nifedipine—CALM2—mammalian vulva—skin cancer	0.000518	0.007	CbGeAlD
Nifedipine—CACNA1H—lymph node—skin cancer	0.000517	0.007	CbGeAlD
Nifedipine—CALM1—mammalian vulva—skin cancer	0.000515	0.00697	CbGeAlD
Nifedipine—ABCC3—head—skin cancer	0.000512	0.00692	CbGeAlD
Nifedipine—ABCC2—female reproductive system—skin cancer	0.00049	0.00662	CbGeAlD
Nifedipine—CACNB2—lymph node—skin cancer	0.000489	0.00661	CbGeAlD
Nifedipine—ABCB1—blood vessel—skin cancer	0.000487	0.00659	CbGeAlD
Nifedipine—CALM2—lymphoid tissue—skin cancer	0.00046	0.00621	CbGeAlD
Nifedipine—CACNA2D1—lymph node—skin cancer	0.000459	0.0062	CbGeAlD
Nifedipine—CALM1—lymphoid tissue—skin cancer	0.000458	0.00619	CbGeAlD
Nifedipine—CYP1A1—epithelium—skin cancer	0.000457	0.00617	CbGeAlD
Nifedipine—CALM2—female reproductive system—skin cancer	0.000443	0.00599	CbGeAlD
Nifedipine—CALM1—female reproductive system—skin cancer	0.000441	0.00597	CbGeAlD
Nifedipine—CYP1A1—skin of body—skin cancer	0.000434	0.00587	CbGeAlD
Nifedipine—CACNA1D—lymph node—skin cancer	0.000427	0.00577	CbGeAlD
Nifedipine—CYP2B6—skin of body—skin cancer	0.000422	0.0057	CbGeAlD
Nifedipine—CYP1A1—mammalian vulva—skin cancer	0.000396	0.00535	CbGeAlD
Nifedipine—CACNA1C—lymph node—skin cancer	0.000394	0.00533	CbGeAlD
Nifedipine—CALM2—head—skin cancer	0.00037	0.00501	CbGeAlD
Nifedipine—CALM1—head—skin cancer	0.000369	0.00498	CbGeAlD
Nifedipine—CYP2C8—female reproductive system—skin cancer	0.000367	0.00497	CbGeAlD
Nifedipine—ABCC3—lymph node—skin cancer	0.000359	0.00485	CbGeAlD
Nifedipine—CYP2B6—lymphoid tissue—skin cancer	0.000342	0.00462	CbGeAlD
Nifedipine—CYP1A1—female reproductive system—skin cancer	0.000339	0.00459	CbGeAlD
Nifedipine—CALM3—lymph node—skin cancer	0.00033	0.00446	CbGeAlD
Nifedipine—CYP2B6—female reproductive system—skin cancer	0.00033	0.00446	CbGeAlD
Nifedipine—CYP2C9—female reproductive system—skin cancer	0.000326	0.00441	CbGeAlD
Nifedipine—CYP2E1—lymphoid tissue—skin cancer	0.000321	0.00434	CbGeAlD
Nifedipine—CYP2E1—female reproductive system—skin cancer	0.000309	0.00418	CbGeAlD
Nifedipine—ABCC2—lymph node—skin cancer	0.000287	0.00387	CbGeAlD
Nifedipine—CYP1A1—head—skin cancer	0.000283	0.00383	CbGeAlD
Nifedipine—CYP2B6—head—skin cancer	0.000275	0.00372	CbGeAlD
Nifedipine—CALM2—lymph node—skin cancer	0.000259	0.00351	CbGeAlD
Nifedipine—CYP2E1—head—skin cancer	0.000258	0.00349	CbGeAlD
Nifedipine—CALM1—lymph node—skin cancer	0.000258	0.00349	CbGeAlD
Nifedipine—CYP3A4—female reproductive system—skin cancer	0.000249	0.00336	CbGeAlD
Nifedipine—CYP2D6—female reproductive system—skin cancer	0.000245	0.00331	CbGeAlD
Nifedipine—Mediastinal disorder—Temozolomide—skin cancer	0.000244	0.00118	CcSEcCtD
Nifedipine—Cough—Bleomycin—skin cancer	0.000244	0.00118	CcSEcCtD
Nifedipine—Chills—Temozolomide—skin cancer	0.000243	0.00118	CcSEcCtD
Nifedipine—Ill-defined disorder—Dactinomycin—skin cancer	0.000242	0.00117	CcSEcCtD
Nifedipine—Anaemia—Dactinomycin—skin cancer	0.000241	0.00117	CcSEcCtD
Nifedipine—Liver function test abnormal—Docetaxel—skin cancer	0.00024	0.00116	CcSEcCtD
Nifedipine—Vomiting—Vemurafenib—skin cancer	0.000239	0.00116	CcSEcCtD
Nifedipine—Alopecia—Temozolomide—skin cancer	0.000239	0.00116	CcSEcCtD
Nifedipine—Chest pain—Bleomycin—skin cancer	0.000238	0.00115	CcSEcCtD
Nifedipine—Myalgia—Bleomycin—skin cancer	0.000238	0.00115	CcSEcCtD
Nifedipine—Orthostatic hypotension—Docetaxel—skin cancer	0.000238	0.00115	CcSEcCtD
Nifedipine—Rash—Vemurafenib—skin cancer	0.000237	0.00115	CcSEcCtD
Nifedipine—Mental disorder—Temozolomide—skin cancer	0.000237	0.00115	CcSEcCtD
Nifedipine—ABCB1—epithelium—skin cancer	0.000237	0.00321	CbGeAlD
Nifedipine—Dermatitis—Vemurafenib—skin cancer	0.000237	0.00115	CcSEcCtD
Nifedipine—Hypersensitivity—Imiquimod—skin cancer	0.000236	0.00114	CcSEcCtD
Nifedipine—Headache—Vemurafenib—skin cancer	0.000236	0.00114	CcSEcCtD
Nifedipine—Erythema—Temozolomide—skin cancer	0.000236	0.00114	CcSEcCtD
Nifedipine—Malnutrition—Temozolomide—skin cancer	0.000236	0.00114	CcSEcCtD
Nifedipine—Breast disorder—Docetaxel—skin cancer	0.000235	0.00114	CcSEcCtD
Nifedipine—Discomfort—Bleomycin—skin cancer	0.000235	0.00114	CcSEcCtD
Nifedipine—Malaise—Dactinomycin—skin cancer	0.000235	0.00114	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000234	0.00113	CcSEcCtD
Nifedipine—Cramp muscle—Docetaxel—skin cancer	0.000234	0.00113	CcSEcCtD
Nifedipine—Leukopenia—Dactinomycin—skin cancer	0.000233	0.00113	CcSEcCtD
Nifedipine—Dysgeusia—Temozolomide—skin cancer	0.000231	0.00112	CcSEcCtD
Nifedipine—Asthenia—Imiquimod—skin cancer	0.00023	0.00111	CcSEcCtD
Nifedipine—Confusional state—Bleomycin—skin cancer	0.00023	0.00111	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00023	0.00111	CcSEcCtD
Nifedipine—Oedema—Bleomycin—skin cancer	0.000228	0.0011	CcSEcCtD
Nifedipine—Anaphylactic shock—Bleomycin—skin cancer	0.000228	0.0011	CcSEcCtD
Nifedipine—Back pain—Temozolomide—skin cancer	0.000228	0.0011	CcSEcCtD
Nifedipine—Pruritus—Imiquimod—skin cancer	0.000227	0.0011	CcSEcCtD
Nifedipine—Dysphagia—Docetaxel—skin cancer	0.000225	0.00109	CcSEcCtD
Nifedipine—Nausea—Vemurafenib—skin cancer	0.000224	0.00108	CcSEcCtD
Nifedipine—Thrombocytopenia—Bleomycin—skin cancer	0.000223	0.00108	CcSEcCtD
Nifedipine—Arrhythmia—Fluorouracil—skin cancer	0.000223	0.00108	CcSEcCtD
Nifedipine—Vision blurred—Temozolomide—skin cancer	0.000222	0.00108	CcSEcCtD
Nifedipine—Myalgia—Dactinomycin—skin cancer	0.000222	0.00107	CcSEcCtD
Nifedipine—Bronchospasm—Docetaxel—skin cancer	0.000221	0.00107	CcSEcCtD
Nifedipine—Tremor—Temozolomide—skin cancer	0.000221	0.00107	CcSEcCtD
Nifedipine—Alopecia—Fluorouracil—skin cancer	0.00022	0.00107	CcSEcCtD
Nifedipine—Diarrhoea—Imiquimod—skin cancer	0.00022	0.00106	CcSEcCtD
Nifedipine—Discomfort—Dactinomycin—skin cancer	0.000219	0.00106	CcSEcCtD
Nifedipine—Angina pectoris—Docetaxel—skin cancer	0.000219	0.00106	CcSEcCtD
Nifedipine—Ill-defined disorder—Temozolomide—skin cancer	0.000219	0.00106	CcSEcCtD
Nifedipine—Anaemia—Temozolomide—skin cancer	0.000218	0.00105	CcSEcCtD
Nifedipine—Anorexia—Bleomycin—skin cancer	0.000217	0.00105	CcSEcCtD
Nifedipine—Erythema—Fluorouracil—skin cancer	0.000217	0.00105	CcSEcCtD
Nifedipine—Agitation—Temozolomide—skin cancer	0.000217	0.00105	CcSEcCtD
Nifedipine—Angioedema—Temozolomide—skin cancer	0.000215	0.00104	CcSEcCtD
Nifedipine—Hypotension—Bleomycin—skin cancer	0.000213	0.00103	CcSEcCtD
Nifedipine—Oedema—Dactinomycin—skin cancer	0.000213	0.00103	CcSEcCtD
Nifedipine—Malaise—Temozolomide—skin cancer	0.000213	0.00103	CcSEcCtD
Nifedipine—Dizziness—Imiquimod—skin cancer	0.000212	0.00103	CcSEcCtD
Nifedipine—Vertigo—Temozolomide—skin cancer	0.000212	0.00103	CcSEcCtD
Nifedipine—Leukopenia—Temozolomide—skin cancer	0.000211	0.00102	CcSEcCtD
Nifedipine—Palpitations—Temozolomide—skin cancer	0.000208	0.00101	CcSEcCtD
Nifedipine—Thrombocytopenia—Dactinomycin—skin cancer	0.000208	0.00101	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000208	0.00101	CcSEcCtD
Nifedipine—ABCB1—mammalian vulva—skin cancer	0.000206	0.00278	CbGeAlD
Nifedipine—Cough—Temozolomide—skin cancer	0.000206	0.000996	CcSEcCtD
Nifedipine—Paraesthesia—Bleomycin—skin cancer	0.000205	0.000991	CcSEcCtD
Nifedipine—Weight increased—Docetaxel—skin cancer	0.000205	0.000991	CcSEcCtD
Nifedipine—Vision blurred—Fluorouracil—skin cancer	0.000205	0.000991	CcSEcCtD
Nifedipine—CYP2D6—head—skin cancer	0.000205	0.00277	CbGeAlD
Nifedipine—Vomiting—Imiquimod—skin cancer	0.000204	0.000988	CcSEcCtD
Nifedipine—Weight decreased—Docetaxel—skin cancer	0.000203	0.000985	CcSEcCtD
Nifedipine—Dyspnoea—Bleomycin—skin cancer	0.000203	0.000984	CcSEcCtD
Nifedipine—Anorexia—Dactinomycin—skin cancer	0.000203	0.000981	CcSEcCtD
Nifedipine—Rash—Imiquimod—skin cancer	0.000202	0.00098	CcSEcCtD
Nifedipine—Dermatitis—Imiquimod—skin cancer	0.000202	0.000979	CcSEcCtD
Nifedipine—Headache—Imiquimod—skin cancer	0.000201	0.000974	CcSEcCtD
Nifedipine—Anaemia—Fluorouracil—skin cancer	0.000201	0.000972	CcSEcCtD
Nifedipine—Myalgia—Temozolomide—skin cancer	0.000201	0.000971	CcSEcCtD
Nifedipine—Arthralgia—Temozolomide—skin cancer	0.000201	0.000971	CcSEcCtD
Nifedipine—Anxiety—Temozolomide—skin cancer	0.0002	0.000968	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000199	0.000965	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000199	0.000963	CcSEcCtD
Nifedipine—CYP1A1—lymph node—skin cancer	0.000198	0.00268	CbGeAlD
Nifedipine—Discomfort—Temozolomide—skin cancer	0.000198	0.00096	CcSEcCtD
Nifedipine—Decreased appetite—Bleomycin—skin cancer	0.000198	0.00096	CcSEcCtD
Nifedipine—Dry mouth—Temozolomide—skin cancer	0.000196	0.00095	CcSEcCtD
Nifedipine—Jaundice—Docetaxel—skin cancer	0.000195	0.000946	CcSEcCtD
Nifedipine—Pain—Bleomycin—skin cancer	0.000195	0.000944	CcSEcCtD
Nifedipine—Conjunctivitis—Docetaxel—skin cancer	0.000195	0.000944	CcSEcCtD
Nifedipine—Leukopenia—Fluorouracil—skin cancer	0.000194	0.000941	CcSEcCtD
Nifedipine—Confusional state—Temozolomide—skin cancer	0.000194	0.000939	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000194	0.000938	CcSEcCtD
Nifedipine—Anaphylactic shock—Temozolomide—skin cancer	0.000192	0.000931	CcSEcCtD
Nifedipine—Oedema—Temozolomide—skin cancer	0.000192	0.000931	CcSEcCtD
Nifedipine—Nausea—Imiquimod—skin cancer	0.000191	0.000923	CcSEcCtD
Nifedipine—Hepatobiliary disease—Docetaxel—skin cancer	0.00019	0.000918	CcSEcCtD
Nifedipine—Epistaxis—Docetaxel—skin cancer	0.000189	0.000916	CcSEcCtD
Nifedipine—Nervous system disorder—Temozolomide—skin cancer	0.000189	0.000913	CcSEcCtD
Nifedipine—Thrombocytopenia—Temozolomide—skin cancer	0.000188	0.000912	CcSEcCtD
Nifedipine—Feeling abnormal—Bleomycin—skin cancer	0.000188	0.00091	CcSEcCtD
Nifedipine—Agranulocytosis—Docetaxel—skin cancer	0.000187	0.000906	CcSEcCtD
Nifedipine—Skin disorder—Temozolomide—skin cancer	0.000187	0.000905	CcSEcCtD
Nifedipine—Hyperhidrosis—Temozolomide—skin cancer	0.000186	0.0009	CcSEcCtD
Nifedipine—Chest pain—Fluorouracil—skin cancer	0.000185	0.000895	CcSEcCtD
Nifedipine—Myalgia—Fluorouracil—skin cancer	0.000185	0.000895	CcSEcCtD
Nifedipine—Decreased appetite—Dactinomycin—skin cancer	0.000185	0.000895	CcSEcCtD
Nifedipine—Fatigue—Dactinomycin—skin cancer	0.000183	0.000888	CcSEcCtD
Nifedipine—Anorexia—Temozolomide—skin cancer	0.000183	0.000888	CcSEcCtD
Nifedipine—ABCB1—lymphoid tissue—skin cancer	0.000183	0.00247	CbGeAlD
Nifedipine—Discomfort—Fluorouracil—skin cancer	0.000183	0.000884	CcSEcCtD
Nifedipine—Pain—Dactinomycin—skin cancer	0.000182	0.00088	CcSEcCtD
Nifedipine—Urticaria—Bleomycin—skin cancer	0.000181	0.000877	CcSEcCtD
Nifedipine—Haemoglobin—Docetaxel—skin cancer	0.000181	0.000876	CcSEcCtD
Nifedipine—Rhinitis—Docetaxel—skin cancer	0.00018	0.000874	CcSEcCtD
Nifedipine—Body temperature increased—Bleomycin—skin cancer	0.00018	0.000873	CcSEcCtD
Nifedipine—Haemorrhage—Docetaxel—skin cancer	0.00018	0.000872	CcSEcCtD
Nifedipine—Hepatitis—Docetaxel—skin cancer	0.00018	0.000872	CcSEcCtD
Nifedipine—Hypoaesthesia—Docetaxel—skin cancer	0.000179	0.000867	CcSEcCtD
Nifedipine—Confusional state—Fluorouracil—skin cancer	0.000179	0.000865	CcSEcCtD
Nifedipine—Pharyngitis—Docetaxel—skin cancer	0.000179	0.000865	CcSEcCtD
Nifedipine—Urinary tract disorder—Docetaxel—skin cancer	0.000178	0.000861	CcSEcCtD
Nifedipine—Oedema peripheral—Docetaxel—skin cancer	0.000177	0.000859	CcSEcCtD
Nifedipine—Anaphylactic shock—Fluorouracil—skin cancer	0.000177	0.000858	CcSEcCtD
Nifedipine—Oedema—Fluorouracil—skin cancer	0.000177	0.000858	CcSEcCtD
Nifedipine—Connective tissue disorder—Docetaxel—skin cancer	0.000177	0.000857	CcSEcCtD
Nifedipine—Urethral disorder—Docetaxel—skin cancer	0.000176	0.000854	CcSEcCtD
Nifedipine—ABCB1—female reproductive system—skin cancer	0.000176	0.00238	CbGeAlD
Nifedipine—Feeling abnormal—Dactinomycin—skin cancer	0.000175	0.000848	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000175	0.000848	CcSEcCtD
Nifedipine—Insomnia—Temozolomide—skin cancer	0.000174	0.000842	CcSEcCtD
Nifedipine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000174	0.000842	CcSEcCtD
Nifedipine—Nervous system disorder—Fluorouracil—skin cancer	0.000174	0.000841	CcSEcCtD
Nifedipine—Thrombocytopenia—Fluorouracil—skin cancer	0.000174	0.00084	CcSEcCtD
Nifedipine—Visual impairment—Docetaxel—skin cancer	0.000173	0.00084	CcSEcCtD
Nifedipine—Tachycardia—Fluorouracil—skin cancer	0.000173	0.000837	CcSEcCtD
Nifedipine—Paraesthesia—Temozolomide—skin cancer	0.000173	0.000836	CcSEcCtD
Nifedipine—Dyspnoea—Temozolomide—skin cancer	0.000171	0.00083	CcSEcCtD
Nifedipine—Somnolence—Temozolomide—skin cancer	0.000171	0.000828	CcSEcCtD
Nifedipine—Erythema multiforme—Docetaxel—skin cancer	0.00017	0.000824	CcSEcCtD
Nifedipine—Dyspepsia—Temozolomide—skin cancer	0.000169	0.00082	CcSEcCtD
Nifedipine—Anorexia—Fluorouracil—skin cancer	0.000169	0.000818	CcSEcCtD
Nifedipine—Eye disorder—Docetaxel—skin cancer	0.000168	0.000815	CcSEcCtD
Nifedipine—Body temperature increased—Dactinomycin—skin cancer	0.000168	0.000814	CcSEcCtD
Nifedipine—Abdominal pain—Dactinomycin—skin cancer	0.000168	0.000814	CcSEcCtD
Nifedipine—Hypersensitivity—Bleomycin—skin cancer	0.000168	0.000813	CcSEcCtD
Nifedipine—Decreased appetite—Temozolomide—skin cancer	0.000167	0.00081	CcSEcCtD
Nifedipine—Cardiac disorder—Docetaxel—skin cancer	0.000167	0.000809	CcSEcCtD
Nifedipine—Flushing—Docetaxel—skin cancer	0.000167	0.000809	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000166	0.000804	CcSEcCtD
Nifedipine—Fatigue—Temozolomide—skin cancer	0.000166	0.000803	CcSEcCtD
Nifedipine—Hypotension—Fluorouracil—skin cancer	0.000166	0.000802	CcSEcCtD
Nifedipine—Pain—Temozolomide—skin cancer	0.000164	0.000796	CcSEcCtD
Nifedipine—Constipation—Temozolomide—skin cancer	0.000164	0.000796	CcSEcCtD
Nifedipine—Asthenia—Bleomycin—skin cancer	0.000164	0.000792	CcSEcCtD
Nifedipine—Angiopathy—Docetaxel—skin cancer	0.000163	0.000791	CcSEcCtD
Nifedipine—Immune system disorder—Docetaxel—skin cancer	0.000163	0.000787	CcSEcCtD
Nifedipine—Mediastinal disorder—Docetaxel—skin cancer	0.000162	0.000786	CcSEcCtD
Nifedipine—Chills—Docetaxel—skin cancer	0.000162	0.000782	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000161	0.000782	CcSEcCtD
Nifedipine—Pruritus—Bleomycin—skin cancer	0.000161	0.000781	CcSEcCtD
Nifedipine—Arrhythmia—Docetaxel—skin cancer	0.000161	0.000779	CcSEcCtD
Nifedipine—Insomnia—Fluorouracil—skin cancer	0.00016	0.000776	CcSEcCtD
Nifedipine—Paraesthesia—Fluorouracil—skin cancer	0.000159	0.00077	CcSEcCtD
Nifedipine—Alopecia—Docetaxel—skin cancer	0.000159	0.00077	CcSEcCtD
Nifedipine—Feeling abnormal—Temozolomide—skin cancer	0.000158	0.000767	CcSEcCtD
Nifedipine—Dyspnoea—Fluorouracil—skin cancer	0.000158	0.000765	CcSEcCtD
Nifedipine—Mental disorder—Docetaxel—skin cancer	0.000158	0.000764	CcSEcCtD
Nifedipine—Somnolence—Fluorouracil—skin cancer	0.000158	0.000763	CcSEcCtD
Nifedipine—Gastrointestinal pain—Temozolomide—skin cancer	0.000157	0.000762	CcSEcCtD
Nifedipine—Malnutrition—Docetaxel—skin cancer	0.000157	0.000759	CcSEcCtD
Nifedipine—Erythema—Docetaxel—skin cancer	0.000157	0.000759	CcSEcCtD
Nifedipine—Hypersensitivity—Dactinomycin—skin cancer	0.000157	0.000759	CcSEcCtD
Nifedipine—Dyspepsia—Fluorouracil—skin cancer	0.000156	0.000755	CcSEcCtD
Nifedipine—Decreased appetite—Fluorouracil—skin cancer	0.000154	0.000746	CcSEcCtD
Nifedipine—Dysgeusia—Docetaxel—skin cancer	0.000153	0.000743	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000153	0.000741	CcSEcCtD
Nifedipine—Urticaria—Temozolomide—skin cancer	0.000153	0.00074	CcSEcCtD
Nifedipine—Asthenia—Dactinomycin—skin cancer	0.000153	0.000739	CcSEcCtD
Nifedipine—Abdominal pain—Temozolomide—skin cancer	0.000152	0.000736	CcSEcCtD
Nifedipine—Body temperature increased—Temozolomide—skin cancer	0.000152	0.000736	CcSEcCtD
Nifedipine—Back pain—Docetaxel—skin cancer	0.000152	0.000734	CcSEcCtD
Nifedipine—Pain—Fluorouracil—skin cancer	0.000152	0.000734	CcSEcCtD
Nifedipine—Muscle spasms—Docetaxel—skin cancer	0.000151	0.00073	CcSEcCtD
Nifedipine—ABCB1—head—skin cancer	0.000147	0.00199	CbGeAlD
Nifedipine—Feeling abnormal—Fluorouracil—skin cancer	0.000146	0.000707	CcSEcCtD
Nifedipine—Diarrhoea—Dactinomycin—skin cancer	0.000145	0.000704	CcSEcCtD
Nifedipine—Vomiting—Bleomycin—skin cancer	0.000145	0.000702	CcSEcCtD
Nifedipine—Anaemia—Docetaxel—skin cancer	0.000145	0.000701	CcSEcCtD
Nifedipine—Rash—Bleomycin—skin cancer	0.000144	0.000696	CcSEcCtD
Nifedipine—Dermatitis—Bleomycin—skin cancer	0.000144	0.000695	CcSEcCtD
Nifedipine—Hypersensitivity—Temozolomide—skin cancer	0.000142	0.000686	CcSEcCtD
Nifedipine—Urticaria—Fluorouracil—skin cancer	0.000141	0.000682	CcSEcCtD
Nifedipine—Syncope—Docetaxel—skin cancer	0.000141	0.00068	CcSEcCtD
Nifedipine—Leukopenia—Docetaxel—skin cancer	0.00014	0.000679	CcSEcCtD
Nifedipine—Body temperature increased—Fluorouracil—skin cancer	0.00014	0.000678	CcSEcCtD
Nifedipine—Palpitations—Docetaxel—skin cancer	0.000138	0.000671	CcSEcCtD
Nifedipine—Asthenia—Temozolomide—skin cancer	0.000138	0.000668	CcSEcCtD
Nifedipine—Loss of consciousness—Docetaxel—skin cancer	0.000138	0.000667	CcSEcCtD
Nifedipine—Cough—Docetaxel—skin cancer	0.000137	0.000662	CcSEcCtD
Nifedipine—Pruritus—Temozolomide—skin cancer	0.000136	0.000659	CcSEcCtD
Nifedipine—Nausea—Bleomycin—skin cancer	0.000135	0.000656	CcSEcCtD
Nifedipine—Vomiting—Dactinomycin—skin cancer	0.000135	0.000655	CcSEcCtD
Nifedipine—Rash—Dactinomycin—skin cancer	0.000134	0.000649	CcSEcCtD
Nifedipine—Myalgia—Docetaxel—skin cancer	0.000133	0.000646	CcSEcCtD
Nifedipine—Chest pain—Docetaxel—skin cancer	0.000133	0.000646	CcSEcCtD
Nifedipine—Arthralgia—Docetaxel—skin cancer	0.000133	0.000646	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000133	0.000642	CcSEcCtD
Nifedipine—Diarrhoea—Temozolomide—skin cancer	0.000132	0.000637	CcSEcCtD
Nifedipine—Hypersensitivity—Fluorouracil—skin cancer	0.000131	0.000632	CcSEcCtD
Nifedipine—Dry mouth—Docetaxel—skin cancer	0.00013	0.000632	CcSEcCtD
Nifedipine—Confusional state—Docetaxel—skin cancer	0.000129	0.000624	CcSEcCtD
Nifedipine—Oedema—Docetaxel—skin cancer	0.000128	0.000619	CcSEcCtD
Nifedipine—Anaphylactic shock—Docetaxel—skin cancer	0.000128	0.000619	CcSEcCtD
Nifedipine—Dizziness—Temozolomide—skin cancer	0.000127	0.000616	CcSEcCtD
Nifedipine—Nausea—Dactinomycin—skin cancer	0.000126	0.000612	CcSEcCtD
Nifedipine—Shock—Docetaxel—skin cancer	0.000126	0.000609	CcSEcCtD
Nifedipine—Nervous system disorder—Docetaxel—skin cancer	0.000125	0.000607	CcSEcCtD
Nifedipine—Pruritus—Fluorouracil—skin cancer	0.000125	0.000607	CcSEcCtD
Nifedipine—Thrombocytopenia—Docetaxel—skin cancer	0.000125	0.000606	CcSEcCtD
Nifedipine—Tachycardia—Docetaxel—skin cancer	0.000125	0.000604	CcSEcCtD
Nifedipine—Skin disorder—Docetaxel—skin cancer	0.000124	0.000602	CcSEcCtD
Nifedipine—Vomiting—Temozolomide—skin cancer	0.000122	0.000592	CcSEcCtD
Nifedipine—Anorexia—Docetaxel—skin cancer	0.000122	0.00059	CcSEcCtD
Nifedipine—Rash—Temozolomide—skin cancer	0.000121	0.000587	CcSEcCtD
Nifedipine—Diarrhoea—Fluorouracil—skin cancer	0.000121	0.000587	CcSEcCtD
Nifedipine—Dermatitis—Temozolomide—skin cancer	0.000121	0.000587	CcSEcCtD
Nifedipine—Headache—Temozolomide—skin cancer	0.00012	0.000583	CcSEcCtD
Nifedipine—Hypotension—Docetaxel—skin cancer	0.00012	0.000579	CcSEcCtD
Nifedipine—Dizziness—Fluorouracil—skin cancer	0.000117	0.000567	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000117	0.000564	CcSEcCtD
Nifedipine—Insomnia—Docetaxel—skin cancer	0.000116	0.00056	CcSEcCtD
Nifedipine—Paraesthesia—Docetaxel—skin cancer	0.000115	0.000556	CcSEcCtD
Nifedipine—Nausea—Temozolomide—skin cancer	0.000114	0.000553	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—skin cancer	0.000114	0.000552	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—skin cancer	0.000114	0.000551	CcSEcCtD
Nifedipine—Vomiting—Fluorouracil—skin cancer	0.000113	0.000546	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—skin cancer	0.000113	0.000545	CcSEcCtD
Nifedipine—Rash—Fluorouracil—skin cancer	0.000112	0.000541	CcSEcCtD
Nifedipine—Dermatitis—Fluorouracil—skin cancer	0.000112	0.000541	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—skin cancer	0.000111	0.000538	CcSEcCtD
Nifedipine—Headache—Fluorouracil—skin cancer	0.000111	0.000538	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00011	0.000535	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—skin cancer	0.00011	0.000534	CcSEcCtD
Nifedipine—Pain—Docetaxel—skin cancer	0.000109	0.00053	CcSEcCtD
Nifedipine—Constipation—Docetaxel—skin cancer	0.000109	0.00053	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—skin cancer	0.000105	0.00051	CcSEcCtD
Nifedipine—Nausea—Fluorouracil—skin cancer	0.000105	0.00051	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—skin cancer	0.000105	0.000506	CcSEcCtD
Nifedipine—ABCB1—lymph node—skin cancer	0.000103	0.00139	CbGeAlD
Nifedipine—Abdominal pain—Docetaxel—skin cancer	0.000101	0.00049	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—skin cancer	0.000101	0.00049	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—skin cancer	9.42e-05	0.000456	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—skin cancer	9.18e-05	0.000444	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—skin cancer	9.05e-05	0.000438	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—skin cancer	8.75e-05	0.000424	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—skin cancer	8.46e-05	0.00041	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—skin cancer	8.13e-05	0.000394	CcSEcCtD
Nifedipine—Rash—Docetaxel—skin cancer	8.06e-05	0.00039	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—skin cancer	8.06e-05	0.00039	CcSEcCtD
Nifedipine—Headache—Docetaxel—skin cancer	8.01e-05	0.000388	CcSEcCtD
Nifedipine—Nausea—Docetaxel—skin cancer	7.6e-05	0.000368	CcSEcCtD
Nifedipine—CALM2—DAP12 signaling—IL6—skin cancer	1.56e-05	0.00037	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CSPG4—skin cancer	1.56e-05	0.00037	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—HRAS—skin cancer	1.55e-05	0.000369	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—HRAS—skin cancer	1.55e-05	0.000368	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PLIN2—skin cancer	1.54e-05	0.000366	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SUFU—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—HRAS—skin cancer	1.53e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—HRAS—skin cancer	1.52e-05	0.00036	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—HRAS—skin cancer	1.52e-05	0.00036	CbGpPWpGaD
Nifedipine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.51e-05	0.00036	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—IL6—skin cancer	1.51e-05	0.00036	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR in disease—IL6—skin cancer	1.51e-05	0.00036	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—IL6—skin cancer	1.51e-05	0.000359	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—HRAS—skin cancer	1.5e-05	0.000357	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—HRAS—skin cancer	1.5e-05	0.000357	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR—IL6—skin cancer	1.5e-05	0.000357	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—HRAS—skin cancer	1.5e-05	0.000356	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—HRAS—skin cancer	1.5e-05	0.000356	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	1.49e-05	0.000353	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SUFU—skin cancer	1.48e-05	0.000352	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SUFU—skin cancer	1.48e-05	0.000352	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—IL6—skin cancer	1.48e-05	0.000352	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—NRAS—skin cancer	1.47e-05	0.00035	CbGpPWpGaD
Nifedipine—CALM3—Immune System—FOXO4—skin cancer	1.47e-05	0.00035	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CSPG4—skin cancer	1.47e-05	0.000349	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—HRAS—skin cancer	1.46e-05	0.000348	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CSPG4—skin cancer	1.45e-05	0.000346	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—IL6—skin cancer	1.45e-05	0.000345	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—IL6—skin cancer	1.45e-05	0.000345	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	1.44e-05	0.000342	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	1.44e-05	0.000342	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—ENO2—skin cancer	1.43e-05	0.000341	CbGpPWpGaD
Nifedipine—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	1.43e-05	0.000341	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—IL6—skin cancer	1.43e-05	0.00034	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—IL6—skin cancer	1.43e-05	0.00034	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—NRAS—skin cancer	1.42e-05	0.000339	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—NRAS—skin cancer	1.42e-05	0.000339	CbGpPWpGaD
Nifedipine—CALM2—Immune System—FOXO4—skin cancer	1.42e-05	0.000338	CbGpPWpGaD
Nifedipine—CALM1—Immune System—FOXO4—skin cancer	1.42e-05	0.000338	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—HRAS—skin cancer	1.41e-05	0.000337	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—HRAS—skin cancer	1.41e-05	0.000337	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ENO2—skin cancer	1.4e-05	0.000334	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ENO2—skin cancer	1.4e-05	0.000333	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	1.4e-05	0.000333	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ENO2—skin cancer	1.4e-05	0.000332	CbGpPWpGaD
Nifedipine—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	1.39e-05	0.00033	CbGpPWpGaD
Nifedipine—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	1.39e-05	0.00033	CbGpPWpGaD
Nifedipine—CALM3—Disease—FOXO4—skin cancer	1.36e-05	0.000323	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	1.35e-05	0.000322	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	1.35e-05	0.000322	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ENO2—skin cancer	1.35e-05	0.000321	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ENO2—skin cancer	1.35e-05	0.000321	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	1.34e-05	0.000319	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.33e-05	0.000315	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—PTGS2—skin cancer	1.32e-05	0.000315	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ENO2—skin cancer	1.32e-05	0.000315	CbGpPWpGaD
Nifedipine—CALM1—Disease—FOXO4—skin cancer	1.31e-05	0.000312	CbGpPWpGaD
Nifedipine—CALM2—Disease—FOXO4—skin cancer	1.31e-05	0.000312	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	1.3e-05	0.000308	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	1.3e-05	0.000308	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—KRAS—skin cancer	1.27e-05	0.000301	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—PTGS2—skin cancer	1.25e-05	0.000298	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CSPG4—skin cancer	1.24e-05	0.000295	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—KRAS—skin cancer	1.23e-05	0.000291	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—KRAS—skin cancer	1.23e-05	0.000291	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ENO2—skin cancer	1.21e-05	0.000289	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PLIN2—skin cancer	1.19e-05	0.000283	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.18e-05	0.00028	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SHH—skin cancer	1.17e-05	0.000277	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RASA1—skin cancer	1.16e-05	0.000276	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SHH—skin cancer	1.13e-05	0.000268	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SHH—skin cancer	1.13e-05	0.000268	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—ERCC2—skin cancer	1.13e-05	0.000268	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RASA1—skin cancer	1.12e-05	0.000267	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RASA1—skin cancer	1.12e-05	0.000267	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTCH1—skin cancer	1.11e-05	0.000263	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SMO—skin cancer	1.11e-05	0.000263	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PTGS2—skin cancer	1.1e-05	0.000262	CbGpPWpGaD
Nifedipine—CALM3—Neuronal System—HRAS—skin cancer	1.1e-05	0.000261	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—HRAS—skin cancer	1.08e-05	0.000256	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTGER4—skin cancer	1.08e-05	0.000256	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTCH1—skin cancer	1.07e-05	0.000254	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTCH1—skin cancer	1.07e-05	0.000254	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SMO—skin cancer	1.07e-05	0.000254	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SMO—skin cancer	1.07e-05	0.000254	CbGpPWpGaD
Nifedipine—CALM2—Neuronal System—HRAS—skin cancer	1.06e-05	0.000253	CbGpPWpGaD
Nifedipine—CALM1—Neuronal System—HRAS—skin cancer	1.06e-05	0.000253	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ENO2—skin cancer	1.06e-05	0.000251	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—HRAS—skin cancer	1.04e-05	0.000248	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—HRAS—skin cancer	1.04e-05	0.000248	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTGER4—skin cancer	1.04e-05	0.000248	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTGER4—skin cancer	1.04e-05	0.000248	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.04e-05	0.000246	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—ERCC2—skin cancer	1.03e-05	0.000245	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—IL6—skin cancer	1.03e-05	0.000245	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—IL6—skin cancer	9.97e-06	0.000237	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—IL6—skin cancer	9.97e-06	0.000237	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ENO2—skin cancer	9.96e-06	0.000237	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PTGS2—skin cancer	9.88e-06	0.000235	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ENO2—skin cancer	9.88e-06	0.000235	CbGpPWpGaD
Nifedipine—CALM3—Disease—ERCC2—skin cancer	9.68e-06	0.00023	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CSPG4—skin cancer	9.58e-06	0.000228	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FOXO4—skin cancer	9.51e-06	0.000226	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.49e-06	0.000226	CbGpPWpGaD
Nifedipine—CALM2—Disease—ERCC2—skin cancer	9.36e-06	0.000223	CbGpPWpGaD
Nifedipine—CALM1—Disease—ERCC2—skin cancer	9.36e-06	0.000223	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—NRAS—skin cancer	9.32e-06	0.000222	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FOXO4—skin cancer	9.2e-06	0.000219	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FOXO4—skin cancer	9.2e-06	0.000219	CbGpPWpGaD
Nifedipine—CALM3—Disease—TERT—skin cancer	9.07e-06	0.000216	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—NRAS—skin cancer	9.02e-06	0.000215	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—NRAS—skin cancer	9.02e-06	0.000215	CbGpPWpGaD
Nifedipine—CALM2—Disease—TERT—skin cancer	8.77e-06	0.000209	CbGpPWpGaD
Nifedipine—CALM1—Disease—TERT—skin cancer	8.77e-06	0.000209	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ENO2—skin cancer	8.44e-06	0.000201	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—NRAS—skin cancer	8.39e-06	0.0002	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—ERCC2—skin cancer	8.33e-06	0.000198	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ERCC2—skin cancer	8.16e-06	0.000194	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ERCC2—skin cancer	8.14e-06	0.000194	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—NRAS—skin cancer	8.12e-06	0.000193	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—NRAS—skin cancer	8.12e-06	0.000193	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ERCC2—skin cancer	8.1e-06	0.000193	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—NRAS—skin cancer	8.06e-06	0.000192	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—KRAS—skin cancer	8.03e-06	0.000191	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ERCC2—skin cancer	7.84e-06	0.000186	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ERCC2—skin cancer	7.84e-06	0.000186	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—NRAS—skin cancer	7.8e-06	0.000185	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—NRAS—skin cancer	7.8e-06	0.000185	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—KRAS—skin cancer	7.76e-06	0.000185	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—KRAS—skin cancer	7.76e-06	0.000185	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.72e-06	0.000184	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ERCC2—skin cancer	7.69e-06	0.000183	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—KRAS—skin cancer	7.22e-06	0.000172	CbGpPWpGaD
Nifedipine—CALM3—Disease—BRAF—skin cancer	7.18e-06	0.000171	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—skin cancer	7.13e-06	0.00017	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ERCC2—skin cancer	7.05e-06	0.000168	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KRAS—skin cancer	6.99e-06	0.000166	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KRAS—skin cancer	6.99e-06	0.000166	CbGpPWpGaD
Nifedipine—CALM2—Disease—BRAF—skin cancer	6.95e-06	0.000165	CbGpPWpGaD
Nifedipine—CALM1—Disease—BRAF—skin cancer	6.95e-06	0.000165	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KRAS—skin cancer	6.94e-06	0.000165	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—skin cancer	6.9e-06	0.000164	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—skin cancer	6.9e-06	0.000164	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—HRAS—skin cancer	6.82e-06	0.000162	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTGS2—skin cancer	6.75e-06	0.000161	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KRAS—skin cancer	6.71e-06	0.00016	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KRAS—skin cancer	6.71e-06	0.00016	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.6e-06	0.000157	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—HRAS—skin cancer	6.6e-06	0.000157	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—HRAS—skin cancer	6.6e-06	0.000157	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ENO2—skin cancer	6.51e-06	0.000155	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TERT—skin cancer	6.35e-06	0.000151	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—skin cancer	6.19e-06	0.000147	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TERT—skin cancer	6.14e-06	0.000146	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TERT—skin cancer	6.14e-06	0.000146	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—HRAS—skin cancer	6.14e-06	0.000146	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ERCC2—skin cancer	6.14e-06	0.000146	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—HRAS—skin cancer	5.94e-06	0.000141	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—HRAS—skin cancer	5.94e-06	0.000141	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HRAS—skin cancer	5.9e-06	0.00014	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—IL6—skin cancer	5.88e-06	0.00014	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—skin cancer	5.8e-06	0.000138	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ERCC2—skin cancer	5.79e-06	0.000138	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ERCC2—skin cancer	5.74e-06	0.000136	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HRAS—skin cancer	5.7e-06	0.000136	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HRAS—skin cancer	5.7e-06	0.000136	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—IL6—skin cancer	5.69e-06	0.000135	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—IL6—skin cancer	5.69e-06	0.000135	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—skin cancer	5.61e-06	0.000134	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—skin cancer	5.61e-06	0.000134	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—NRAS—skin cancer	5.35e-06	0.000127	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—NRAS—skin cancer	5.18e-06	0.000123	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—NRAS—skin cancer	5.18e-06	0.000123	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—BRAF—skin cancer	5.03e-06	0.00012	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—skin cancer	4.99e-06	0.000119	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ERCC2—skin cancer	4.9e-06	0.000117	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—skin cancer	4.89e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NRAS—skin cancer	4.89e-06	0.000116	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—skin cancer	4.88e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—BRAF—skin cancer	4.87e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—BRAF—skin cancer	4.87e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—skin cancer	4.86e-06	0.000116	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—skin cancer	4.73e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—skin cancer	4.73e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—skin cancer	4.7e-06	0.000112	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—skin cancer	4.7e-06	0.000112	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—skin cancer	4.61e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—skin cancer	4.61e-06	0.00011	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—skin cancer	4.51e-06	0.000107	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—skin cancer	4.46e-06	0.000106	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—skin cancer	4.46e-06	0.000106	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—skin cancer	4.37e-06	0.000104	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—skin cancer	4.37e-06	0.000104	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—skin cancer	4.23e-06	0.000101	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—skin cancer	4.21e-06	0.0001	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—skin cancer	4.07e-06	9.68e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—skin cancer	4.07e-06	9.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—skin cancer	3.91e-06	9.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—skin cancer	3.89e-06	9.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—skin cancer	3.79e-06	9.01e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—skin cancer	3.79e-06	9.01e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ERCC2—skin cancer	3.78e-06	9e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—skin cancer	3.76e-06	8.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—skin cancer	3.76e-06	8.94e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—skin cancer	3.75e-06	8.91e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—skin cancer	3.68e-06	8.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—skin cancer	3.62e-06	8.62e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—skin cancer	3.62e-06	8.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—skin cancer	3.58e-06	8.51e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—skin cancer	3.47e-06	8.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—skin cancer	3.46e-06	8.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—skin cancer	3.46e-06	8.23e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—skin cancer	3.44e-06	8.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—skin cancer	3.42e-06	8.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—skin cancer	3.31e-06	7.88e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—skin cancer	3.31e-06	7.88e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—skin cancer	3.3e-06	7.86e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—skin cancer	3.19e-06	7.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—skin cancer	3.19e-06	7.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—skin cancer	3.16e-06	7.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—skin cancer	3.16e-06	7.52e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—skin cancer	3.06e-06	7.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—skin cancer	3.06e-06	7.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—skin cancer	3.06e-06	7.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—skin cancer	3.06e-06	7.27e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—skin cancer	2.94e-06	6.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—skin cancer	2.72e-06	6.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—skin cancer	2.63e-06	6.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—skin cancer	2.63e-06	6.26e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—skin cancer	2.42e-06	5.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—skin cancer	2.34e-06	5.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—skin cancer	2.34e-06	5.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—skin cancer	2.31e-06	5.5e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—skin cancer	2.27e-06	5.4e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—skin cancer	2.24e-06	5.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—skin cancer	2.24e-06	5.32e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—skin cancer	2.21e-06	5.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—skin cancer	2.14e-06	5.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—skin cancer	2.14e-06	5.09e-05	CbGpPWpGaD
